SCHEMBL26688606

SCHEMBL26688606

CCN(CCc1c[nH]c2c(C)ccc(O)c12)Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 4/20 0.51
▸ TRPM8 Q7Z2W7 1/20 0.47
▸ TRPV1 Q8NER1 1/20 0.47
▸ HTR6 P50406 2/20 0.43
▸ HDAC1 Q13547 2/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ HTR2A P28223 2/20 0.41
▸ HTR1D P28221 3/20 0.39
▸ DRD1 P21728 1/20 0.39
▸ HTR1B P28222 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ HTR1E P28566 1/20 0.39
▸ ADORA2A P29274 1/20 0.39
▸ ADORA2B P29275 1/20 0.39
▸ HTR7 P34969 1/20 0.39
▸ DRD3 P35462 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ HTR5A P47898 1/20 0.39
▸ APP P05067 3/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30756808 1.00 HTR1A (0.51) HTR1ATRPM8TRPV1HTR6HDAC1
SCHEMBL25244986 0.88 HTR1A (0.60) HTR1AHTR6HTR2AHTR1DDRD1
SCHEMBL31105616 0.82 HTR1A (0.45) HTR1ATRPM8TRPV1HTR6HDAC1
SCHEMBL25239276 0.81 HTR1A (0.52) HTR1AHTR6HTR2AHTR1DDRD1
SCHEMBL31105724 0.81 HTR1A (0.79) HTR1ATRPM8TRPV1HTR6HDAC1
SCHEMBL25029867 0.80 HTR1A (0.57) HTR1AHTR6HTR2AHTR1DDRD1
SCHEMBL25029851 0.77 HTR1A (0.72) HTR1AHTR6HTR2AHTR1DDRD1
SCHEMBL25008690 0.77 HTR1A (0.50) HTR1AHTR6HDAC1KCNH2HTR2A
SCHEMBL31077923 0.76 HTR1A (0.56) HTR1AHTR6HTR2AHTR1DDRD1
SCHEMBL25288798 0.76 HTR1A (0.56) HTR1AHTR6HTR2AHTR1DDRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240294538-A1 Serotonin Receptor Agonists and Methods of Making and Using the Same KULEON LLC (US) 2024-09-05 — — US disclosed
WO-2023225043-A1 TRICYCLIC AND TETRACYCLIC SEROTONIN RECEPTOR MODULATORS AND METHODS OF MAKING AND USING THE SAME KULEON LLC (US) 2023-11-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294538-A1 Serotonin Receptor Agonists and Methods of Making and Using the Same HTR1A, HTR7, HTR3A HTR1A 1/4885TRPM8 670/4885TRPV1 413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback